Affymetrix announced this week that President and CEO Kevin King will step down at the end of June to "pursue other interests."
King will be replaced by Dionex President and CEO Frank Witney, who some years ago, served as Affymetrix's executive VP and COO.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.